Pediatrix (MD) Reports Q1 EPS Beat with Revenue of $476 Million

Pediatrix Medical Group, Inc. (MD) reported Q1 adjusted EPS of $0.44, surpassing the consensus estimate of $0.38. Revenue for the quarter totaled $476 million, exceeding the expected $465.82 million. Same-unit revenue from net reimbursement-related factors grew 4.4% year over year. The company reaffirmed its FY26 adjusted EBITDA outlook of $280 million to $300 million. Analysts from Jefferies raised their price target on MD to $27 while Truist increased theirs to $23, reflecting confidence in the company's performance amid healthcare service demand trends.